News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-12-04 4:31:52 am Coeptis Therapeutics to Present at the Emerging Growth Conference PRNewsWire
2023-10-31 6:1:0 am Coeptis Therapeutics Announces Research Demonstrating the Potential of SNAP-CAR T-cells to Reduce Tumor Burden and Growth in HER2 and CD20 Expressing Cancers Will be Presented at SITC 2023 PR Newswire
2023-10-24 5:30:0 am Coeptis Therapeutics Announces $2 Million Private Placement PR Newswire
2023-10-11 4:30:0 am Coeptis Therapeutics Expands License Agreement with University of Pittsburgh to Include SNAP-CAR NK Cell Technology PR Newswire
2023-10-09 6:15:0 am Coeptis Therapeutics to Participate in Panel at the BioFlorida Conference Discussing Emerging Cell and Gene Therapies PR Newswire
2023-10-04 4:30:0 am Coeptis Therapeutics Announces Research Involving SNAP-CAR Accepted for Presentation at the Society for Immunotherapy of Cancer's 38th Annual Meeting PR Newswire
2023-09-27 4:30:0 am Coeptis Therapeutics to Present at the 2023 Cell & Gene Meeting on the Mesa PR Newswire
2023-09-14 4:30:0 am Coeptis Therapeutics Provides Safety and Dosing Update from Phase 1 Trials Investigating DVX201 in Relapsed/Refractory AML or High Risk MDS and Hospitalized COVID-19 Infection PR Newswire
2023-09-11 4:30:0 am Coeptis Therapeutics Announces Deverra Therapeutics Has Received Two Life Science Start-Up and Development Awards and Associated Grant from Washington's Cancer Research Endowment PR Newswire
   

Please consider a small donation if you think this website provides you with relevant information